Using a mortar and pestle for medication compounding presents numerous challenges to today’s pharmacists. In fact, concerns with dose uniformity, compound quality, cross-contamination, and worker safety have consistently created problems. But QuartetRx—a new, superior liquid compounding system—makes compounding much easier, safer, and faster.
P&C Pharma’s QuartetRx provides superior compounds and costs savings to every pharmacy. QuartetRx is the industry's first automated oral liquid compounding device that improves business volume and margin for pharmacies through compounding efficiency.
QuartetRx allows pharmacists to compound high-quality multi-dose oral liquids from tablets, capsules, and drug powders. A unique wet milling process consistently yields small rounded particles of medication, which suspend easily and are less prone to clumping or caking, ensuring dose uniformity.
In fact, QuartetRx can compound up to four medications simultaneously within 20 minutes using highly engineered, single-use containers and a wet milling process.
P&C Pharma is a life-science company developing novel technologies to produce personalized pharmaceutical products for human and veterinary patients. P&C Pharma's first product is the QuartetRx® Automated Compounding System. QuartetRx provides an alternative medication administration option for patients who cannot be administered solid oral medications due to swallowing problems.
In addition to working as a CNA for the past 13 years, Lucie has broad experience in communications, editing, writing, public relations and research, both in the private sector and for non-profits. For the last several years, she has actively worked as a communications, marketing and PR consultant for numerous clients, most notably CVS Health, Towers Watson, Mars Inc, ReadyTech, Ancestry, Aartrijk, Wildflower Health, Communication Partners Inc, ExpertBeacon, Liberty Global, Acrobatiq and Words & Numbers.
This post is related to:
USP <795> Non-Sterile Resources, Compliance, Technology
